EPO Patents = 4

Forward Citations = 6

Loading Chart...

4 inventors (with patents filed for the assignee):

Matthew J Sharp (5 out of 8 patents)

William R Moore, Jr (4 out of 4 patents)

Daniel Bucks (3 out of 11 patents)

4. Philip J Birbara (3 out of 61 patents)

5. Charles A Birbara (0 patent)

6. Mary Coughlin (0 patent)

8 patents: Sort by Forward Citations

1. 12138273 - Abiraterone prodrugs (2024-11-12),

2. 11957696 - Abiraterone prodrugs (2024-04-16),

3. 11737994 - Topical compositions for pain relief, manufacture and use (2023-08-29),

4. 11559534 - Abiraterone prodrugs (2023-01-24),

5. 11246872 - Topical acyclovir formulations and uses thereof (2022-02-15),

6. 11123315 - Topical compositions for pain relief, manufacture and use (2021-09-21),

7. 10821088 - Pain relief compositions, manufacture and uses (2020-11-03),

8. 10792292 - Abiraterone prodrugs (2020-10-06),

Propella Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for the treatment of cancer. With a focus on precision medicine, Propella Therapeutics leverages cutting-edge technologies to target specific genetic mutations in order to tailor treatment plans for each individual patient. The company's mission is to improve outcomes for cancer patients by providing personalized, effective therapies that target the underlying molecular drivers of their disease.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

8 Patents

#4 in Pittsboro, NC

#730 in North Carolina

#34,918 in US

Pittsboro, NC, United States of America

Propella Therapeutics, Inc.